Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

yttrium Y 90 ibritumomab tiuxetan

A radioimmunotherapeutic agent consisting of a murine monoclonal anti-CD20 antibody (ibritumomab) linked by the chelator tiuxetan to the radioisotope yttrium-90 (Y 90). Yttrium Y 90 ibritumomab tiuxetan binds to and specifically delivers beta radiation to CD20-expressing tumor cells, thereby minimizing the systemic effects of radiation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:90Y ibritumomab tiuxetan
IDEC-Y2B8 monoclonal antibody
Y90 Zevalin
Code name:IDEC Y2B8
NSC code:710085
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search